Genome Browser
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
564
NCT04513652
A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution
Phase: Phase 3
Role: Lead Sponsor
Start: Sep 3, 2020
Completion: Dec 17, 2020
NCT04759339
An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920
Phase: Phase 1
Start: Feb 24, 2021
Completion: Feb 25, 2021
NCT04829344
Start: Mar 30, 2021
Completion: May 10, 2021
NCT05325853
A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population
Start: Apr 6, 2022
Completion: May 27, 2022
NCT05501860
A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution
Start: Jul 30, 2022
Completion: Dec 7, 2022
Loading map...